Yahoo Web Search

Search results

    • BioSyent Releases Financial Results for Q1 2024

      Digital Journal· 3 hours ago

      I look forward to reporting on our progress in 2024.” The CEO’s presentation on the...BioSyent is a profitable growth-oriented specialty pharmaceutical company focused on in-licensing or acquiring ...